Results 101 to 110 of about 860,404 (335)

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

open access: yesMolecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice   +16 more
wiley   +1 more source

Qualitative Research in Sport Sciences: Is the Biomedical Ethics Model Applicable?

open access: yesForum: Qualitative Social Research, 2003
Research in sports science has historically been grounded in positivist traditions. This means that ethics committees may not be adequately sensitized to the ethical problems posed by qualitative research.
Steve Olivier, Lesley Fishwick
doaj  

Ethnographic Intimacy: Thinking Through the Ethics of Social Research in Sex Worlds [PDF]

open access: yes
Ethnographic researchers entering sensitive fields of research become entangled in ethical dilemmas when they encounter \'sticky\' questions, situations and issues.
Maria P�rez-y-P�rez, Tony Stanley
core  

Ethical approval in developing countries is not optional [PDF]

open access: yes, 2012
When conducting health and medical research it is not only important to do the research ethically, but also to apply for prior ethical approval from the relevant authorities.
Simkhada, Padam, van Teijlingen, Edwin
core   +1 more source

Co-design and implementation research: challenges and solutions for ethics committees

open access: yesBMC Medical Ethics, 2015
BackgroundImplementation science research, especially when using participatory and co-design approaches, raises unique challenges for research ethics committees.
F. Goodyear-Smith   +2 more
semanticscholar   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

Controvérsias sobre a revisão ética de pesquisas em ciências humanas e sociais pelo Sistema CEP/Conep

open access: yesRevista Bioética
O comitê de ética em pesquisa tem como função revisar todas as pesquisas envolvendo seres humanos realizadas no Brasil, o que tem suscitado controvérsias sobre a revisão ética de pesquisas em ciências humanas e sociais. O objetivo deste artigo é discutir
Adriana Silva Barbosa   +2 more
doaj   +1 more source

Getting Beyond Form Filling: The Role of Institutional Governance in Human Research Ethics [PDF]

open access: yes, 2018
It has become almost a truism to describe the interaction between research ethics committees and researchers as being marred by distrust and conflict.
Allen, Gary
core  

Research ethics committees deserve support [PDF]

open access: yesBMJ, 2005
I agree with Wade that audit and certain kinds of research have similarities in purpose, structure, and ethics and that audit is not reviewed within the same strict ethical guidelines.1 However, this does not indicate that “research and audit cannot be distinguished.” The definitions and differences have been published.2 3 Audit and research surveys ...
openaire   +2 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy